相似文献
1
Alterations of microRNAs contribute to colon carcinogenesis.
Semin Oncol. 2011 Dec;38(6):734-42. doi: 10.1053/j.seminoncol.2011.08.009.
2
MicroRNAs and inflammation in the pathogenesis and progression of colon cancer.
Dig Dis. 2012;30 Suppl 2(Suppl 2):9-15. doi: 10.1159/000341882. Epub 2012 Nov 23.
3
Role of MicroRNAs in the Progression and Metastasis of Colon Cancer.
Endocr Metab Immune Disord Drug Targets. 2021;21(1):35-46. doi: 10.2174/1871530320666200825184924.
4
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
JAMA. 2008 Jan 30;299(4):425-36. doi: 10.1001/jama.299.4.425.
5
MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity.
World J Gastroenterol. 2015 Jul 21;21(27):8284-92. doi: 10.3748/wjg.v21.i27.8284.
6
Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.
Carcinogenesis. 2016 Oct;37(10):941-950. doi: 10.1093/carcin/bgw078. Epub 2016 Aug 1.
7
The pathological role of microRNAs and inflammation in colon carcinogenesis.
Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):174-9. doi: 10.1016/j.clinre.2014.06.013. Epub 2014 Aug 19.
8
A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
Neoplasma. 2017;64(1):56-64. doi: 10.4149/neo_2017_107.
9
Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.
Clin Cancer Res. 2009 Sep 15;15(18):5878-87. doi: 10.1158/1078-0432.CCR-09-0627. Epub 2009 Sep 8.
10
Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study.
BMC Med Genomics. 2016 Apr 23;9(1):21. doi: 10.1186/s12920-016-0181-x.
引用本文的文献
1
Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer.
Hum Gene Ther. 2024 Oct;35(19-20):855-867. doi: 10.1089/hum.2023.207. Epub 2024 Jul 4.
2
Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets-A Review.
Curr Issues Mol Biol. 2023 Apr 3;45(4):2917-2936. doi: 10.3390/cimb45040191.
3
Validation of Urinary Charged Metabolite Profiles in Colorectal Cancer Using Capillary Electrophoresis-Mass Spectrometry.
Metabolites. 2022 Jan 10;12(1):59. doi: 10.3390/metabo12010059.
4
The Clinical Assessment of MicroRNA Diagnostic, Prognostic, and Theranostic Value in Colorectal Cancer.
Cancers (Basel). 2021 Jun 11;13(12):2916. doi: 10.3390/cancers13122916.
5
MicroRNA-21 is upregulated during intestinal barrier dysfunction induced by ischemia reperfusion.
Kaohsiung J Med Sci. 2018 Oct;34(10):556-563. doi: 10.1016/j.kjms.2018.05.006. Epub 2018 Jun 7.
6
Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs.
Sci Rep. 2018 Sep 27;8(1):14477. doi: 10.1038/s41598-018-32734-2.
7
Identification of microRNA-124 in regulation of Hepatocellular carcinoma through BIRC3 and the NF-κB pathway.
J Cancer. 2018 Jul 30;9(17):3006-3015. doi: 10.7150/jca.25956. eCollection 2018.
8
Evaluation of miR-21 Inhibition and its Impact on Cancer Susceptibility Candidate 2 Long Noncoding RNA in Colorectal Cancer Cell Line.
Adv Biomed Res. 2018 Jan 30;7:14. doi: 10.4103/abr.abr_214_16. eCollection 2018.
9
miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion.
Oncol Lett. 2018 Jan;15(1):1097-1102. doi: 10.3892/ol.2017.7432. Epub 2017 Nov 16.
10
MicroRNA-338-3p Suppresses Proliferation of Human Liver Cancer Cells by Targeting SphK2.
Oncol Res. 2018 Sep 14;26(8):1183-1189. doi: 10.3727/096504018X15151495109394. Epub 2018 Jan 10.
本文引用的文献
1
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
2
IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis.
Cancer Res. 2010 Oct 15;70(20):8108-16. doi: 10.1158/0008-5472.CAN-10-2579. Epub 2010 Sep 2.
3
Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.
Cancer Genet Cytogenet. 2010 Jul 15;200(2):154-60. doi: 10.1016/j.cancergencyto.2010.04.015.
4
The role of the miR-200 family in epithelial-mesenchymal transition.
Cancer Biol Ther. 2010 Aug 1;10(3):219-22. doi: 10.4161/cbt.10.3.12548.
5
Fecal MicroRNAs as novel biomarkers for colon cancer screening.
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1766-74. doi: 10.1158/1055-9965.EPI-10-0027. Epub 2010 Jun 15.
6
Genetic variation in microRNA networks: the implications for cancer research.
Nat Rev Cancer. 2010 Jun;10(6):389-402. doi: 10.1038/nrc2867.
7
Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB.
Mol Cancer Res. 2010 May;8(5):691-700. doi: 10.1158/1541-7786.MCR-09-0465. Epub 2010 May 11.
8
Foxo3a regulates apoptosis by negatively targeting miR-21.
J Biol Chem. 2010 May 28;285(22):16958-66. doi: 10.1074/jbc.M109.093005. Epub 2010 Apr 6.
9
Modulation of mismatch repair and genomic stability by miR-155.
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6982-7. doi: 10.1073/pnas.1002472107. Epub 2010 Mar 29.
10
The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.
Eur J Cancer. 2010 Jun;46(9):1640-9. doi: 10.1016/j.ejca.2010.02.003. Epub 2010 Mar 8.
Zotero 插件